These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 33712565)

  • 1. EphA2 super-enhancer promotes tumor progression by recruiting FOSL2 and TCF7L2 to activate the target gene EphA2.
    Cui S; Wu Q; Liu M; Su M; Liu S; Shao L; Han X; He H
    Cell Death Dis; 2021 Mar; 12(3):264. PubMed ID: 33712565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Long Non-Coding RNA CRNDE Promotes Colorectal Carcinoma Progression by Competitively Binding miR-217 with TCF7L2 and Enhancing the Wnt/β-Catenin Signaling Pathway.
    Yu B; Ye X; Du Q; Zhu B; Zhai Q; Li XX
    Cell Physiol Biochem; 2017; 41(6):2489-2502. PubMed ID: 28472810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-302b inhibits tumorigenesis by targeting EphA2 via Wnt/ β-catenin/EMT signaling cascade in gastric cancer.
    Huang J; He Y; Mcleod HL; Xie Y; Xiao D; Hu H; Chen P; Shen L; Zeng S; Yin X; Ge J; Li L; Tang L; Ma J; Chen Z
    BMC Cancer; 2017 Dec; 17(1):886. PubMed ID: 29273006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DKK1-SE recruits AP1 to activate the target gene DKK1 thereby promoting pancreatic cancer progression.
    Shao L; Yu H; Wang M; Chen L; Ji B; Wu T; Teng X; Su M; Han X; Shi W; Hu X; Wang Z; He H; Han G; Zhang Y; Wu Q
    Cell Death Dis; 2024 Aug; 15(8):566. PubMed ID: 39107271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hsa_circ_0001869 promotes NSCLC progression via sponging miR-638 and enhancing FOSL2 expression.
    Xu P; Wang L; Xie X; Hu F; Yang Q; Hu R; Jiang L; Ding F; Mei J; Liu J; Xiao H
    Aging (Albany NY); 2020 Nov; 12(23):23836-23848. PubMed ID: 33221767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Super-Enhancer-Associated Oncogenes in Osteosarcoma with THZ2, a Covalent CDK7 Inhibitor.
    Zhang J; Liu W; Zou C; Zhao Z; Lai Y; Shi Z; Xie X; Huang G; Wang Y; Zhang X; Fan Z; Su Q; Yin J; Shen J
    Clin Cancer Res; 2020 Jun; 26(11):2681-2692. PubMed ID: 31937612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EphA2 promotes epithelial-mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer cells.
    Huang J; Xiao D; Li G; Ma J; Chen P; Yuan W; Hou F; Ge J; Zhong M; Tang Y; Xia X; Chen Z
    Oncogene; 2014 May; 33(21):2737-47. PubMed ID: 23752181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An oncogenic enhancer promotes melanoma progression via regulating ETV4 expression.
    Zhang J; Wang Q; Qi S; Duan Y; Liu Z; Liu J; Zhang Z; Li C
    J Transl Med; 2024 Jun; 22(1):547. PubMed ID: 38849954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual targeting of EphA2 and ER restores tamoxifen sensitivity in ER/EphA2-positive breast cancer.
    Gökmen-Polar Y; Toroni RA; Hocevar BA; Badve S; Zhao Q; Shen C; Bruckheimer E; Kinch MS; Miller KD
    Breast Cancer Res Treat; 2011 Jun; 127(2):375-84. PubMed ID: 20602165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of super-enhancer-driven tumor suppressor gene RCAN1.4 expression promotes the malignancy of breast carcinoma.
    Deng R; Huang JH; Wang Y; Zhou LH; Wang ZF; Hu BX; Chen YH; Yang D; Mai J; Li ZL; Zhang HL; Huang Y; Peng XD; Feng GK; Zhu XF; Tang J
    Mol Cancer; 2020 Aug; 19(1):122. PubMed ID: 32771023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression.
    Chen X; Wang X; Ruan A; Han W; Zhao Y; Lu X; Xiao P; Shi H; Wang R; Chen L; Chen S; Du Q; Yang H; Zhang X
    Clin Cancer Res; 2014 May; 20(10):2617-30. PubMed ID: 24647573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Claudin-4 controls the receptor tyrosine kinase EphA2 pro-oncogenic switch through β-catenin.
    Shang X; Lin X; Howell SB
    Cell Commun Signal; 2014 Oct; 12():59. PubMed ID: 25344320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Super-enhancer-associated SNHG15 cooperating with FOSL1 contributes to bladder cancer progression through the WNT pathway.
    Tan M; Pan Q; Gong H; Zhai X; Wan Z; Ge M; Gu J; Zhang D; Chen X; Xu D
    Pharmacol Res; 2023 Nov; 197():106940. PubMed ID: 37758102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ephexin4 and EphA2 mediate resistance to anoikis through RhoG and phosphatidylinositol 3-kinase.
    Harada K; Hiramoto-Yamaki N; Negishi M; Katoh H
    Exp Cell Res; 2011 Jul; 317(12):1701-13. PubMed ID: 21621533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced YB1/EphA2 axis signaling promotes acquired resistance to sunitinib and metastatic potential in renal cell carcinoma.
    Ruan H; Li S; Bao L; Zhang X
    Oncogene; 2020 Sep; 39(38):6113-6128. PubMed ID: 32814829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-22-3p targeted regulating transcription factor 7-like 2 (TCF7L2) constrains the Wnt/β-catenin pathway and malignant behavior in osteosarcoma.
    Xue Y; Guo Y; Liu N; Meng X
    Bioengineered; 2022 Apr; 13(4):9135-9147. PubMed ID: 34753394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA SNHG16 promotes non-small cell lung cancer development through regulating EphA2 expression by sponging miR-520a-3p.
    Yu L; Chen D; Song J
    Thorac Cancer; 2020 Mar; 11(3):603-611. PubMed ID: 31953899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S897 phosphorylation of EphA2 is indispensable for EphA2-dependent nasopharyngeal carcinoma cell invasion, metastasis and stem properties.
    Li JY; Xiao T; Yi HM; Yi H; Feng J; Zhu JF; Huang W; Lu SS; Zhou YH; Li XH; Xiao ZQ
    Cancer Lett; 2019 Mar; 444():162-174. PubMed ID: 30583071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.
    Brantley-Sieders DM; Zhuang G; Hicks D; Fang WB; Hwang Y; Cates JM; Coffman K; Jackson D; Bruckheimer E; Muraoka-Cook RS; Chen J
    J Clin Invest; 2008 Jan; 118(1):64-78. PubMed ID: 18079969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt/β-catenin signaling regulated SATB1 promotes colorectal cancer tumorigenesis and progression.
    Mir R; Pradhan SJ; Patil P; Mulherkar R; Galande S
    Oncogene; 2016 Mar; 35(13):1679-91. PubMed ID: 26165840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.